Chromone-Based Antioxidant Copper(II) Complex with High Superoxide Dismutase Activity.

Area of Science:

• Medicinal Chemistry
• Biochemistry
• Materials Science

Background:

• Transition metal complexes can mimic superoxide dismutase (SOD) enzymes for antioxidant therapy.
• Chromone-based compounds show antioxidant potential but suffer from poor solubility and metal binding.
• Developing novel ligands is crucial for enhancing the efficacy of metal-based antioxidants.

Purpose of the Study:

• To synthesize and characterize a novel chromone-based ligand, ChroHis, with improved properties.
• To investigate the complexation of ChroHis with copper(II) and evaluate its antioxidant capabilities.
• To assess the therapeutic potential of the copper(II)/ChroHis complex for diseases involving elevated superoxide levels.

Main Methods:

• Synthesis of ChroHis ligand and its copper(II) complexes.
• Solution equilibrium studies and spectroscopic analyses (e.g., UV-Vis, EPR).
• Electrochemical studies (cyclic voltammetry) and enzymatic assays (SOD activity tests).
• In vitro cell viability and proliferation assays.

Main Results:

• ChroHis exhibits enhanced water solubility and forms stable dimeric copper(II) complexes.
• The copper(II)/ChroHis complex displays optimal redox potentials for superoxide dismutation.
• Excellent SOD activity and significant antioxidant efficacy were confirmed through kinetic and biochemical assays.
• The complex demonstrated negligible cytotoxicity in vitro, indicating a wide safety margin.

Conclusions:

• The novel ChroHis ligand facilitates the formation of stable, highly active copper(II) complexes.
• The Cu(II)/ChroHis complex possesses potent SOD activity and favorable thermodynamic stability.
• Its non-toxic profile and high efficacy suggest strong potential for antioxidant therapeutic applications.